In hepatobiliarydisease and biliary obstruction, bilirubin often becomes covalentlybound to albumin circulatingin serum, producinga nondissociablecomplex.To determinehow long this complexed bilirubinremains in the circulation,we compared the metabolicclearance of bilirubin-albumincomplexes with the clearances of free bilirubin and unmodified albumin. Radiolabeled bilirubin, albumin, and covalent bilirubin-albumin were injected into the circulation of SpragueDawley rats and serial samples of plasmawere analyzedfor the injected compounds.The halt-lifeof bilirubinwas 6.2 mm. The half-lifeof bilirubincovalentlybound to rat serum albumin was 1.9 to 2.1 days, identical to that of unmodified rat albumin. We conclude that bilirubincovalently attached to albuminis maintainedin the circulation with the long half-life Here we set out to determine how long the covalent bilirubin-albumin complexes were retained in the circulation relative to bilirubin itself and to albumin.
Dawley rats and serial samples of plasmawere analyzedfor the injected compounds.The halt-lifeof bilirubinwas 6.2 mm. The half-lifeof bilirubincovalentlybound to rat serum albumin was 1.9 to 2.1 days, identical to that of unmodified rat albumin. We conclude that bilirubincovalently attached to albuminis maintainedin the circulation with the long half-life of albumin rather than the short half-life of bilirubin. Because albumin in humans has a half-life of 19 Here we set out to determine how long the covalent bilirubin-albumin complexes were retained in the circulation relative to bilirubin itself and to albumin.
Materials and Methods

Preparation of Albumins
Albumin was isolated from rat serum by affinity chromatography on Afllgel Blue (Bio-Rad, Richmond, CA) and a column of human albumin immobilized on agarose to remove any uncoupled biirubin and through a Sephadex G-100 column to isolate albumin monomer. The eluent was phosphate-buffered saline (0.1 mol NaC1, 16.2 mmol Na2HPO4, 3.7 mmol NaII2PO4 per liter), pH 7.4. Albumin immobilized on agarose was prepared as previously described (10).
To determine the amount of bilirubin covalently attached to albumin we measured the radioactivity associated with the complex formed from [3lflbilirubin (5 Ci/mol) or the absorbance at 453 nm for the complex prepared from nonradioactive biirubin (molar absorptivity of bilirubin attached to rat albumin = 44500 L . mol' -cm1). Albumin concentration was determined by the biuret reaction
(11).
To determine whether the biirubin moiety attached to albumin was the free acid form or the esterified form, we diazotized bilirubin-albumin with the diazomum salt of ethyl anthranilate and separated the cleaved dipyrrole azopigments by thin-layer chromatography on silica gel as described by Heirwegh et al. (12) . For iodination of albumin we used "lodo-Beads" (Pierce Chemical Co., Rockford, IL) and Na'311 or NalmI (New England Nuclear, Boston, MA). Less than 1 mol of iodine was incorporated per mole of albumin. lodination of the covalent bilirubin-albumin complexes caused a loss of <12% of the intensity of the bilirubin absorption at 453 rim. Thus, the mild oxidizing conditions for iodination did not destroy the bilirubin label.
Turnover Studies
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Male Sprague-Dawley rats were injected in a lateral tail vein with 300 L of solution containing 10 mg of albumin (5 zCi of 'I-labeled albumin-bilirubin and 10 pCi of 131j.. labeled albumin as a control for basal albumin turnover).
Blood from the opposite lateral tail vein was collected into heparinized tubes daily for seven days. The radioactivity in aliquots of plasma was counted with a Beckman 5500 gamma counter with 1I and 1311windows. This radioactivity was >95% precipitable with 50 g/L perchloric acid, showing that the radioactive iodine had remained attached to protein.
To verify that bilirubin was not cleaved from the covalent complex in the circulation, 1 pCi of [3H}bilirubin-albumin (15mg of albumin) was injected into the lateral tail vein and monitored by serial plasma samples as described for the iodinated albumins.
[3HlBilirubin-albumin radioactivity was counted in a Beckman 7500 LS scintillation counter.
To determine the turnover of bilirubin in rats, we anesthetized them with sodium pentabarbital, passed a 10-cm catheter of no. 50 polyethylene tubing through the left carotid artery to the aortic arch, and clamped the catheter shut. We then injected 10 pCi of [3Hlbilirubin in 300 jzL of phosphate buffer containing 6.6 mg of rat serum albumin into a lateral tail vein (rat 1) or into the jugular vein (rat 2). Samples of blood were collected from the carotid artery at 30-s intervals by unclamping the catheter and collecting blood into heparinized tubes. The radioactivity in 25-pL aliquots of the resulting plasma was counted.
The half4ife for each compound in the plasma was calculated from the linear regression analysis of a plot of log(disintegrations/mm) vs time.
Results
Characterization of the bilirubin-aThumin complex. For this work we used synthetic covalent biirubin-albuinin complexes prepared from biirubin esterifled with Woodward's Reagent K rather than from bilirubin esterifled with glucuronic acid, because we needed quantities of bilirubin covalently attached to albumin that are not readily prepared from biirubin-glucuronide systems. To characterize our synthetic material, we cleaved the covalently attached bilirubin with the diazonium salt of ethyl anthranilic acid to produce two azodipyrroles, one of which remained covalently attached to albumin, the other being extracted into ethyl acetate. The extracted azodipyrrole was chromatographed by thin-layer chromatography and compared with similarly treated azodipyrroles generated from free bilirubin and from bilirubin esterified with Woodward's Reagent K. More than 70% of the azodipyrrole cleaved from the covalently attached bilirubin was found to be unconjugated; <30% was esterified with Woodward's Reagent K. Naturally occurring bilirubin-albumin complexes from rats yield between 50%
and 80% unconjugated azodipyrrole and those from humans are >70% unconjugated azodipyrrole, with the remainder being mostly glucuronide conjugate (2, 13) . Therefore, the synthetic biirubin-albumin used in this work, like the complexes formed in vivo, contained primarily unconjugated bilirubin coupled to albumin. Less than 30% of the synthetic bilirubin-albumin was esterified by Woodward's Reagent K (252 Da) and less than 30% of the naturally occurring bilirubin-albumin was esterifled by glucuronic acid (194 Da).
Turnover studies. Turnover of I-labeled albumin-bilirubin was determined at the same time as the turnover of control '311-labeled albumin in each of seven rats (Table 1) To assure ourselves that the attached bilirubin was not cleaved from albumin in the circulation, such that unmodified albumin would be compared with modified albumin, we also prepared [3Hlbilirubin-albumin and injected this into two rats. The results were similar to the values determined with iodinated albumin species (Figure 1, Table 1 ). This demonstrates that the bilirubin label is not cleaved from circulating albumin but rather that the bilirubin is maintained in the serum covalently attached to albumin.
In contrast, when [3Hjbiirubin was injected into the circulation in association with, but not covalently attached to, albumin it quickly disappeared from the circulation (Figure 2 ). As calculated with a single-compartment model, its half-life was only 6.2 (0.3 SD) ruin.
Discussion
We have shown that covalent biirubin-albumin complexes remain in the circulation of rats with the two-day half-life of albumin rather than the 6-mm half-life of unconjugated bilirubin. Therefore, the covalent attachment of biirubin to albumin generates a form of bilirubin whose half-life is In contrast, bilirubin itself is cleared rapidly from the circulation of both rats and humans. Similar to the observations depicted in Figure 2 , Wolkoff et al. (16) reported that 36% of an injection of [3H]bilirubin in Sprague-Dawley rats was cleared by the liver within 1.5 nun, and that by 15 mm as much as 64% of the total injected bilirubin was conjugated to glucuromde by the liver. Studies with human subjects (17) showed that elimination of ['4C]bilirubin over a 28-h period was better described by a three-compartment model than a simple one-compartment model but, in agreement with the results reported in this paper, most of the unconjugated bilirubin was eliminated from the circulation rapidly, with a half-life of <18 mm.
Although it is unusual to find more than one molecule of bilirubin carried by an albumin molecule in icteric serum, albumin is believed to have three binding sites for bilirubin (18, 19) . It is not known whether the albumin site that is occupied in spontaneously formed covalent complexes with bilirubin is the primary bilirubin-binding site or one of the secondary sites. Because the location of covalently bound bilirubin could affect the structure and catabolism of albumin, we prepared complexes of bilirubin-albunun with bilirubin attached to one, two, or three sites. No differences were seen in turnover rates for the three different bilirubin complexes, indicating that the prolonged metabolic life of covalently bound bilirubin is not a function of the particular site on albumin to which it is attached.
No metabolic consequence of the prolonged presence of covalent biirubin-albumin complexes in the circulation has been documented. However, covalent attachment of bilirubin to albumin does interfere with dye-binding assays for quantifying albumin, presumably by irreversible occupancy of a potential dye-binding site by a bilirubin molecule, resulting in an underestimation of albumin concentration (20 
